In 289 UK children aged 6–12 with myopia, daily atropine 0.01% eye drops for two years reduced myopia progression versus placebo (mean difference 0.33 D; 230 analysed) and axial elongation (0.14 mm), with larger pupils but no difference in adverse events.
RCTn = 289
Azuara-Blanco et al. Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK)